Pathogenesis and treatment for type 2 diabetes mellitus combined with frailty and sarcopenia

VernacularTitle:2型糖尿病合并衰弱和肌少症的机制与治疗
Author: Yiyin CHEN ; Lele PENG ; Peiru HE ; Junkun ZHAN ; Youshuo LIU
From: Chinese Journal of Geriatrics 2021;40(1):124-127
CountryChina
Language:Chinese
Abstract: The prevalence of type 2 diabetes mellitus(T2DM)in China is about 9.1%.Compared with healthy adults, life expectancy for patients with T2DM at 60 years of age can be cut short by 7.3-9.5 years and time for a good quality of life by 11.1-13.8 years.It is important for elderly patients with T2DM to stay functionally active.Frailty, as a common geriatric syndrome, is an important factor affecting the functional status of the elderly, a strong predictor for disability, death and hospitalization, and also a strong predictor for adverse health outcomes in elderly patients with T2DM.This article reviews the relationship between frailty/sarcopenia and T2DM, and the management and treatment of elderly T2DM patients with frailty/sarcopenia.